In subjects with childhood or young-onset insulin-treated diabetes, recent population-based studies have shown that algorithms including the absence of markers of autoimmune type 1 diabetes [5–7] and the presence of detectable insulin secretion [7] improved differential diagnosis between type 1 diabetes and monogenic diabetes. This evidence concerns the gene INS and diabetes mellitus.